Health knowledge made personal
WellPage for Common Effect Of Long Term Use Of Glucocorticoids To Treat Rheumatoid Arthritis
+ Bookmark › Share
Go
Search posts:

Common Effect Of Long Term Use Of Glucocorticoids To Treat Rheumatoid Arthritis - Articles

Osteoarthritis: A review of trea ... by Dr. Rubens D. Medical Doctor Posted Thu 07 May 2009 8:19pm Osteoarthritis: A review of treatment options 08 may 2009--Osteoarthritis (OA), also known as degenerative joint disease (DJD), is the most common form of arthritis in the United States. 1 Although OA can occur in any synovial joint in the body, it most commonly affects the knees, hips, and hands. OA is the leading ... Read on »
Cushing's syndrome by Dr. Anshu Gupta Patient Expert Posted Tue 02 Jun 2009 4:39pm Cushing's syndrome is a hormonal disorder caused by prolonged exposure of the body's tissues to high levels of the hormone cortisol. Sometimes called "hypercortisolism," it is relatively rare and most commonly affects adults aged 20 to 50. An estimated 10 to 15 of every million people are affected each year. What are the symptoms? S ... Read on »
FDA Approves Rituxan to Treat Two Rare Disorders by Medline Plus Posted Tue 19 Apr 2011 5:59pm FDA approves Rituxan to treat two rare disorders The U.S. Food and Drug Administration today approved Rituxan (rituximab), in combination with glucocorticoids (steroids), to treat patients with Wegener’s granulomatosis (WG) and microscopic polyangiitis (MPA), two rare disorders that cause blood vessel inflammation (vasculitis) ... Read on »
FDA approves Rituxan to treat two rare disorders by Health: Hearsay & Headlines Posted Wed 20 Apr 2011 12:00am The U.S. Food and Drug Administration today approved Rituxan (rituximab), in combination with glucocorticoids (steroids), to treat patients with Wegener’s granulomatosis (WG) and microscopic polyangiitis (MPA), two rare disorders that cause blood vessel inflammation (vasculitis). Vasculitis in patients with WG and MPA can lead to tissue d ... Read on »
Prognosis and Hope: Lupus Fact #28 – Normal life span expected with current treatment standards by Lupus Adventurer Posted Mon 28 May 2012 5:49pm Prognosis and Hope: With current methods of therapy, 80 to 90 percent of people with non-organ threatening lupus can look forward to a normal lifespan.  This puts about 10 to 20 percent of in a somewhat different minority group, but with proper treatment these people can expect to live long, full productive lives, too. Medication standa ... Read on »
Finn Family Immune Toll: H1N1 Vaccine and Narcolepsy in Finnish Children by Kim S. Patient Expert Posted Thu 01 Sep 2011 12:00am By Adriana Gamondes Due to a “pandemic” of two children infected with a new strain of swine flu after exposure to pigs, the  CDC is  gearing up for the new swine flu, H3N2. . But then, buzz kill, it turns out that children are at a thirteen fold  risk of developing narcolepsy from the squalene and thimerosal containing ... Read on »
Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis by Jan Posted Fri 11 Sep 2009 4:57pm 1 Comment BY Alisa E Koch and Oliver Distler Angiogenesis is important in the pathogenesis of systemic inflammatory rheumatic diseases, a family of related disorders that includes rheumatoid arthritis and systemic sclerosis. Rheumatoid arthritis is the rheumatic disease in which the role of angiogenesis has been studied most extensively. However, wher ... Read on »
ANTI-INFLAMMATORY DRUG RESEARCH by Stephen Tvedten Patient Expert Posted Wed 08 Dec 2010 9:16am ANTI-INFLAMMATORY DRUG RESEARCH – A Pointer To The Better Role Of Phytochemicals From Fruits And Berries (A Short Note) Beldeu Singh Billions of dollars have been spent on research and production of anti-inflammatory drugs but they are all toxic. These drugs were developed with the intention to find chemicals that will suppress the Cox-2 ... Read on »
Systemic sclerosis and related connective tissue diseases: present and future by Jan Posted Sat 07 Nov 2009 10:02pm By Lewis J. Rubin and Colleague In April 2006, 30 international experts gathered in Athens, Greece, to discuss systemic sclerosis (SSc) and related connective tissue diseases (CTDs). SSc is a clinically heterogeneous and complex disease that is characterized by vascular dysfunction, vascular and extravascular fibrosis, and characteristic immune ... Read on »
Health Headlines - October 29 by Meredy Registered NurseHealth Maven Posted Wed 28 Oct 2009 11:01pm High-Fiber Foods May Protect Against Inflammatory Diseases: Study A high-fiber diet may boost the immune system and help prevent inflammatory diseases such as asthma, diabetes and arthritis, say Australian researchers and their colleagues. In the gut, high-fiber foods are converted by bacteria into short chain fatty acids, which are known t ... Read on »